The effect of PRDX6 loss has been studied in two tumoral hepatocarcinoma cell lines [21,22] with different degrees of differentiation, HepG2 and SNU475, but, still, it is unknown whether it can be extrapolated to other tumors including human colorectal carcinoma. This evidence concerns the gene PRDX6 and colorectal carcinoma.